Neogen Corporation’s Naltrexone/Nalbuphine ELISA (Enzyme-Linked ImmunoSorbent Assay) test kit is a qualitative one-step kit designed for use as a screening device for the detection of Naltrexone, Nalbuphine, and/or other metabolites. The kit was designed for screening purposes and is intended for forensic use only.
Intended Use
For the determination of trace quantities of Naltrexone and Nalbuphine and/or other metabolites in human urine, blood or oral fluid. Contact a Neogen representative for information on other matrices.
Sensitivity
| Compound | I-50 in EIA Buffer |
| Naltrexone | 2.36 ng/mL |
| Nalbuphine | 1.17 ng/mL |
Specificity (Cross-Reactivity)
| Compound | Cross-Reactivity |
| Nalbuphine | 202% |
| Naltrexone | 100% |
| Naltriben | 41% |
| Butorphanol | 28% |
| Nalmefene | 26% |
| 6β-Naltrexol | 6.5% |
| 3-Methoxynaltrexone | 6.3% |
| Naloxone | 4% |
| Nalorphine | 1.3% |
| Pentazocine | 0.29% |
| Codeine | 0.02% |
Order Details
| Product # | Product Description |
| 133019 | Naltrexone/Nalbuphine, 96 well kit |
| 133015 | Naltrexone/Nalbuphine, 480 well kit |
For forensic use only.